This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.

Gynecologic Oncology Update
Claim This Podcastby Dr. Neil Love
Podcast Authority
Beta
Podcast Overview
This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.
Language
🇺🇲
Publishing Since
2/12/2008
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind Gynecologic Oncology Update
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes

August 1, 2026
TROP2- and CDH6-Directed ADCs in Gynecologic Cancers — An Interview with Dr Ramez Eskander on Key Presentations from the Society of Gynecologic Oncology 2026 Annual Meeting
<p>Featuring an interview with Dr Ramez Eskander, including the following topics:</p><ul><li>Overview of antibody-drug conjugates (ADCs) and their role in the management of gynecologic cancers; considerations in sequencing (0:00)</li><li>Choosing between FRɑ- and HER2-directed ADCs for dually eligible patients; role of antigenic target in predicting efficacy benefit of ADCs (7:53)</li><li>Comparative efficacy and safety of ADCs and conventional chemotherapy (12:58)</li><li>Current and investigational targets of ADCs in gynecologic cancers (17:14)</li><li>Current research surrounding raludotatug deruxtecan (R-DXd) and its potential role in clinical practice (21:56)</li><li>Safety and tolerability profiles of ADCs, including R-DXd, and potential mitigation strategies (27:36)</li><li>Overview of available TROP2-directed ADCs for gynecologic cancers, including key clinical data (33:34)</li><li>Evolving use of TROP2-directed ADCs for gynecologic cancers in clinical trials (39:05)</li><li>Oral mucositis/stomatitis associated with TROP2-directed ADCs and potential mitigation strategies (44:38)</li></ul><br/><p><a href="https://researchtopractice.com/SGO26/Review/ADCsGyn/Video" rel="noopener noreferrer" target="_blank">CME information and select publications</a></p>

July 23, 2026
For Oncology Nurses: Ovarian Cancer — Proceedings from the 2026 Annual ONS Congress
<p>Featuring perspectives from Dr Bradley J Monk, Dr David M O’Malley, Ms Kathryn M Schlenker and Ms Jaclyn Shaver, moderated by Dr O’Malley, including the following topics: </p><ul><li>Introduction<strong> </strong>(00:00)</li><li>Overview of Ovarian Cancer (OC) (2:12)</li><li>Role of PARP Inhibitors in Advanced OC (4:56)</li><li>Current and Potential Future Role of Mirvetuximab Soravtansine in OC (28:45)</li><li>Role of Relacorilant in Advanced OC (57:08)</li><li>Utility of Immune Checkpoint Inhibition in Advanced OC (1:14:12)</li></ul><br/><p><u><a href="https://researchtopractice.com/ONS2026/Ovarian/Video" rel="noopener noreferrer" target="_blank">NCPD information and select publications</a></u></p>

July 20, 2026
Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
<p>Featuring perspectives from Dr Floor J Backes, Dr Brian M Slomovitz and Dr Shannon N Westin, moderated by Dr Westin, including the following topics:</p><ul><li>Introduction<strong> </strong>(00:00)</li><li>Current Up-Front Chemoimmunotherapeutic Approaches for Advanced Endometrial Cancer (EC) — Dr Backes (1:50)</li><li>Current and Future Role of Anti-PD-1/PD-L1 Antibodies in Combination with Systemic Therapies Beyond Chemotherapy for Advanced EC — Dr Westin (33:15)</li><li>Promising Agents Under Investigation for EC — Dr Slomovitz (1:01:41)</li></ul><br/><p><u><a href="https://researchtopractice.com/ASCO2026/Endometrial/Video" rel="noopener noreferrer" target="_blank">CME information and select publications</a></u></p>
147 total episodes available
Recent guests on Gynecologic Oncology Update
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Joyce F Liu
Guest
David M O’Malley
Guest
Ritu Salani
Guest
Alessandro D Santin
Guest
Courtney Arn
Guest
Jennifer Filipi
Guest
Dr Ritu Salani
Guest
Dr Brian Slomovitz
Guest
Kathryn Lyle
Guest
Jaclyn Shaver
Guest
Similar Podcasts
Discover related shows you might enjoy

SGO on the GO
The Society of Gynecologic Oncology

ASCO Daily News
American Society of Clinical Oncology (ASCO)

Two Onc Docs
Sam and Karine

IJGC conversations
ijgcgroup

Gastrointestinal Cancer Update
Dr. Neil Love

JAMA Clinical Reviews
JAMA Network

Ready, Set, GYO!
Ready, Set, GYO: An educational gynecologic oncology podcast

Breast Cancer Update
Dr. Neil Love

Lung Cancer Update
Dr. Neil Love

Prostate Cancer Update
Dr. Neil Love

Huberman Lab
Scicomm Media

NEJM This Week
NEJM Group

The Mel Robbins Podcast
Mel Robbins

Oncology Today with Dr Neil Love
Dr. Neil Love
Deep-dive analytics for Gynecologic Oncology Update
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Gynecologic Oncology Update?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.